VSTM FY 2025 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena

VSTMVerastem, Inc.

$388M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$31M+209.1% YoY

Gross Profit

$00.0% margin

Operating Income

-$170M-550.3% margin

Net Income

-$209M-677.6% margin

EPS (Diluted)

$-3.02

Cash Flow

Operating Cash Flow

-$138M

Free Cash Flow

-$138M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$246M

Total Liabilities

$189M

Stockholders' Equity

$57M

Cash & Equivalents

$205M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$10M	+209.1%
Gross Profit	$0	$10M	-100.0%
Operating Income	-$170M	-$115M	-48.0%
Net Income	-$209M	-$131M	-60.3%